Related references
Note: Only part of the references are listed.Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia
Franc Llorens et al.
ALZHEIMERS & DEMENTIA (2016)
Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders
Zheng-Yu Wang et al.
INTERNATIONAL PSYCHOGERIATRICS (2015)
Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD
Franc Llorens et al.
JOURNAL OF NEUROLOGY (2015)
Increased albumin CSF/serum ratio in dementia with Lewy bodies
Franc Llorens et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
News and controversies regarding essential tremor
E. Boutin et al.
REVUE NEUROLOGIQUE (2015)
Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis
Liang Gao et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2015)
CSF biomarkers and clinical progression of Parkinson disease
Sara Hall et al.
NEUROLOGY (2015)
The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease
X. Li et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
Takashi Kasai et al.
JOURNAL OF NEUROLOGY (2014)
Reduced Alpha-Synuclein in Cerebrospinal Fluid in Synucleinopathies: Evidence From a Meta-analysis
Wataru Sako et al.
MOVEMENT DISORDERS (2014)
The neurobiological basis of cognitive impairment in Parkinson's disease
Glenda M. Halliday et al.
MOVEMENT DISORDERS (2014)
Biomarkers in biological fluids for dementia with Lewy bodies
Sebastian Schade et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies
S. A. Vann Jones et al.
PSYCHOLOGICAL MEDICINE (2014)
CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA (2013)
The diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementia with Lewy bodies - A systematic review and meta-analysis
Xuxin Lim et al.
PARKINSONISM & RELATED DISORDERS (2013)
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
Sara Hall et al.
ARCHIVES OF NEUROLOGY (2012)
Neurochemistry and the non-motor aspects of PD
I. Ferrer et al.
NEUROBIOLOGY OF DISEASE (2012)
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
N. S. M. Schoonenboom et al.
NEUROLOGY (2012)
Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid
Niels Kruse et al.
METHODS (2012)
α-Synuclein in Parkinson disease and other neurodegenerative disorders
Michael Eller et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Tau and p-tau as CSF biomarkers in dementia: a meta-analysis
Argonde C. van Harten et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (vol 10, pg 230, 2011)
B. Mollenhauer et al.
LANCET NEUROLOGY (2011)
Cerebrospinal Fluid Tau/α-Synuclein Ratio in Parkinson's Disease and Degenerative Dementias
Lucilla Parnetti et al.
MOVEMENT DISORDERS (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Brit Mollenhauer et al.
LANCET NEUROLOGY (2011)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola et al.
ARCHIVES OF NEUROLOGY (2009)
A critical evaluation of current staging of α-synuclein pathology in Lewy body disorders
Kurt A. Jellinger
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Cerebrospinal Fluid alpha-Synuclein Does Not Discriminate Between Dementia Disorders
Petra E. Spies et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Cerebrospinal fluid α-synuclein in neurodegenerative disorders-A marker of synapse loss?
Annika Ohrfelt et al.
NEUROSCIENCE LETTERS (2009)
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Brit Mollenhauer et al.
EXPERIMENTAL NEUROLOGY (2008)
Second consensus statement on the diagnosis of multiple system atrophy
S. Gilman et al.
NEUROLOGY (2008)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop
Ian G. McKeith
JOURNAL OF ALZHEIMERS DISEASE (2006)
A systematic review of prevalence and incidence studies of dementia with Lewy bodies
J Zaccai et al.
AGE AND AGEING (2005)
Essential tremor associated with focal nonnigral Lewy bodies - A clinicopathologic study
ED Louis et al.
ARCHIVES OF NEUROLOGY (2005)
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2002)
Synucleinopathies - Clinical and pathological implications
JE Galvin et al.
ARCHIVES OF NEUROLOGY (2001)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
